Home › Astrocytoma › Texas › Houston
Astrocytoma clinical trials in Houston, TX
14 studies for Astrocytoma are looking for participants at sites in and around Houston (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
MSC-DNX-2401 in Treating Patients With Recurrent High-Grade Glioma
RecruitingPhase 1
- M D Anderson Cancer Center, Houston
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
RecruitingPhase 1/2
- The University of Texas MD Anderson Cancer Center, Houston
Targeted Pediatric High-Grade Glioma Therapy
RecruitingObservational study
- Texas Children's Hospital, Houston
HSV G207 in Children With Recurrent or Refractory Cerebellar Brain Tumors
RecruitingPhase 1
- MD Anderson Cancer Center, Houston
Study of Olutasidenib and Temozolomide in HGG
RecruitingPhase 2
- Texas Children's Hospital, Houston
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
RecruitingPhase 3
- MD Anderson Cancer Center, Houston
Study of AZD9574 as Monotherapy and in Combination With Anti-cancer Agents in Participants With Advanced Solid Malignancies
RecruitingPhase 1/2
- Research Site, Houston
Study of 203Pb-RMX-VH-PIB Dosimetry and Biodistribution in Patients With Glioblastoma Multiform (GBM) and Pancreatic Ductal Adenocarcinoma (PDAC)
RecruitingPhase 1
- Excel Diagnostics & Nuclear Oncology Center, Houston
Chemotherapy and Radiation Therapy for the Treatment of IDH Wildtype Gliomas or Non-histological (Molecular) Glioblastomas
RecruitingPhase 2
- M D Anderson Cancer Center, Houston
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
RecruitingEarly phase 1Healthy volunteers welcome
- Texas Children's Hospital, Houston
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
RecruitingPhase 2
- Texas Children's Hospital, Houston
HSV-tk + Valacyclovir + SBRT + Chemotherapy for Recurrent GBM
RecruitingPhase 1/2
- Houston Methodist Neurological Institute, Houston
HSV-tk and XRT and Chemotherapy for Newly Diagnosed GBM
RecruitingPhase 1/2
- Houston Methodist Neurological Institute, Houston
Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
RecruitingPhase 1
- UT MD Anderson Cancer Center, Houston
Astrocytoma trials in other cities
- Boston, MA13 studies
- Chicago, IL9 studies
- New York City, NY9 studies
- Philadelphia, PA7 studies
- Miami, FL7 studies
- Washington, DC6 studies
- Durham, NC6 studies
- Seattle, WA6 studies
- Columbus, OH6 studies
- San Francisco, CA6 studies
- Aurora, CO5 studies
- Cincinnati, OH5 studies
Other studies in Houston
- Non-Small Cell Lung Cancer145 studies
- Breast Cancer126 studies
- Cancer (all types)121 studies
- Metastatic Cancer104 studies
- Colorectal Cancer102 studies
- Ovarian Cancer89 studies
- Acute Myeloid Leukemia85 studies
- Lung Cancer78 studies
- Prostate Cancer76 studies
- Endometrial Cancer68 studies
- Pancreatic Cancer61 studies
- Melanoma59 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.